Pregnant Women Injected With Banned, Blacklisted Pharma Company’s Shot; Five Women Lose Memory And..

In a shocking incident in Gujarat, five pregnant women reportedly lost their memory after receiving injections from a blacklisted pharmaceutical company. The case of gross negligence occurred at Sanjay Gandhi Medical College in Rewa. According to reports, the women were administered a medicine that had already been banned and blacklisted. Following the injection, all five women began exhibiting symptoms of memory loss. An initial investigation suggests the injection was mistakenly issued by the hospital’s storekeeper.

The First Complaint Came From Vidisha

A complaint regarding this injection was first received from Vidisha Medical College in October 2024, after which the medicine was banned. Gujarat-based Radiant Parenterals Limited company was officially blacklisted following the report in December. Reports suggests that the pharmacist had issued the banned medicine, and appropriate action has been taken against him.

Gujarat-based Radiant Parenterals Limited

The storekeeper has been suspended in connection with the incident, but no action has been taken against other officials so far. Due to this negligence, the pharmaceutical company has also been fined and blacklisted. The incident occurred at Sanjay Gandhi Medical College in Rewa.

What Happened At Sanjay Gandhi Medical College

At Sanjay Gandhi Medical College in Rewa, five pregnant women were administered an anesthesia injection manufactured by Gujarat-based Radiant Parenterals Limited. The company had already been blacklisted in December due to poor quality standards of its injections.

Banned Injection Issued By Storekeeper

The investigation revealed that hospital storekeeper Praveen Upadhyay mistakenly issued the banned injection, leading to his suspension. However, despite the gravity of the incident, no action was taken against other responsible officials. The probe also uncovered serious lapses in medicine storage—temperature was not properly monitored, inventory records were poorly maintained, and expired or substandard drugs were stored alongside approved ones.

Gujarat-based Radiant Parenterals Limited Banned For 5 Years

The company has been debarred from undertaking any government contracts for five years and blacklisted for two years. Additionally, a fine of ₹3.01 lakh has been imposed on the company. The use of the injection produced by Radiant Parenterals Limited was banned.

Related Posts

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Hyderabad – A groundbreaking study by the Indian Council of Medical Research’s National Institute of Nutrition (ICMR-NIN) has established a clear association between micronutrient deficiencies and elevated dementia risk among Indian…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Drug companies directed to step up vigil on adverse reactions

Drug companies directed to step up vigil on adverse reactions